FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales
FDA announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.
